0001564590-18-006225 Sample Contracts

Change of Control Severance Agreement
Change of Control Severance Agreement • March 19th, 2018 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus

This letter sets forth the agreement between you and T2 Biosystems, Inc. (the “Company”) regarding certain terms and conditions of your employment.

AutoNDA by SimpleDocs
CO-DEVELOPMENT, COLLABORATION AND CO-MARKETING AGREEMENT
Co-Development, Collaboration and Co-Marketing Agreement • March 19th, 2018 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • New York

This Co-Development, Collaboration and Co-Marketing Agreement (the “ Agreement ”) is entered into on November 1, 2016 (the “ Effective Date ”) by and between T2 Biosystems, Inc. , a Delaware corporation (“ T2 Bio ”), having its principal offices at 101 Hartwell Avenue, Lexington, Massachusetts 02421, and Allergan Sales, LLC , a Delaware limited liability company (“ Allergan ”), having its principal offices at Morris Corporate Center III, 400 Interpace Parkway, Parsippany, NJ 07054. T2 Bio and Allergan are each a “ Party ” and together the “ Parties ” to this Agreement.

T2 BIOSYSTEMS, INC.
Severance Agreement • March 19th, 2018 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus

This letter sets forth the agreement between you and T2 Biosystems, Inc. (the “Company”) regarding certain terms and conditions of your employment. You are entitled to receive the following:

TERM LOAN AGREEMENT dated as of December 30, 2016 among T2 BIOSYSTEMS, INC., as Borrower, the Subsidiary Guarantors from time to time party hereto, the Lenders from time to time party hereto, and CRG SERVICING LLC, as Administrative Agent and...
Term Loan Agreement • March 19th, 2018 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • New York

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

AMENDMENT NO. 3 TO COMMERCIAL LEASE BETWEEN COLUMBUS DAY REALTY, INC., AND T2 BIOSYSTEMS, INC.
Commercial Lease • March 19th, 2018 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus

This Amendment No. 3 is to a Commercial Lease dated May 6, 2013, by and between Columbus Day Realty, Inc. (LESSOR), and T2 Biosystems, Inc. (LESSEE), which lease relates to the premises at 231 Andover Street, Wilmington, Massachusetts.

AMENDMENT TO SEVERANCE AND CHANGE IN CONTROL AGREEMENT
Severance and Change in Control Agreement • March 19th, 2018 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus

This Amendment to Severance and Change in Control Agreement is entered into as of March 6, 2018, by and between T2 Biosystems, Inc., a Delaware corporation having its principal place of business at 101 Hartwell Avenue, Lexington, Massachusetts 02421 USA (“T2 Bio”) and Alec Barclay (“Employee”). Capitalized terms used herein without definition shall have the meaning ascribed thereto in the Severance / Change in Control Agreement (as defined below).

AMENDMENT No. 3 TO TERM LOAN AGREEMENT
Term Loan Agreement • March 19th, 2018 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • New York

THIS AMENDMENT NO. 3 TO TERM LOAN AGREEMENT, dated as of March 16, 2018 (this “Amendment”) is made among T2 BIOSYSTEMS, INC., a Delaware corporation (“Borrower”), CRG SERVICING LLC, as administrative agent and collateral agent (in such capacities, “Administrative Agent”) and the lenders listed on the signature pages hereof under the heading “LENDERS” (each, a “Lender” and, collectively, the “Lenders”), with respect to the Loan Agreement described below.

AMENDMENT NO. 2 TO COMMERCIAL LEASE BETWEEN COLUMBUS DAY REALTY, INC., AND T2 BIOSYSTEMS, INC.
Commercial Lease • March 19th, 2018 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus

This Amendment No. 2 is to a Commercial Lease dated May 6, 2013, by and between Columbus Day Realty, Inc. (LESSOR), and T2 Biosystems, Inc. (LESSEE), which lease relates to the premises at 231 Andover Street, Wilmington, Massachusetts.

AMENDMENT NUMBER THREE TO CONSULTING AGREEMENT
Consulting Agreement • March 19th, 2018 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus

This Amendment Number Three to Consulting Agreement (this “Amendment”) is entered into this 13th day of October, 2017, between T2 Biosystems, Inc., a Delaware corporation (the "Company"), and Dr. Robert Langer (the “Consultant”). Capitalized terms used herein without definition shall have the meaning ascribed thereto in the Consulting Agreement (as defined below).

AMENDMENT No. 2 TO TERM LOAN AGREEMENT
Term Loan Agreement • March 19th, 2018 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • New York

THIS AMENDMENT NO. 2 TO TERM LOAN AGREEMENT, dated as of December 18, 2017 (this “Amendment”) is made among T2 BIOSYSTEMS, INC., a Delaware corporation (“Borrower”), CRG SERVICING LLC, as administrative agent and collateral agent (in such capacities, “Administrative Agent”) and the lenders listed on the signature pages hereof under the heading “LENDERS” (each, a “Lender” and, collectively, the “Lenders”), with respect to the Loan Agreement described below.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!